Dae-In LEE

Dr. Dae-In LEE

Chungbuk National University Hospital, Cheongju-si, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
MYMin-Uk Yang
Min-Uk Yang
DLDae-In LEE
Dae-In LEE
SPSeung Park
Seung Park

6 September 2023 in European Journal of Preventive Cardiology
Verified
Journal Article
Open access
PDF file
JLJae-Woo Leea
Jae-Woo Leea
SRSeung-Young Roh
Seung-Young Roh
WYWoong-Su Yoon
Woong-Su Yoon
JKJinseob Kim
Jinseob Kim
EJEunseo Jo
Eunseo Jo
DLDae-In LEE
Dae-In LEE
Heavy alcohol consumption is an established risk factor for atrial fibrillation (AF). However, the association between habitual changes in heavy habitual drinkers and incident AF remains unclear. The aim of this study was to evaluate whether absolute abstinence or reduced drinking decreases incident AF in heavy habitual drinkers. Atrial fibrillation-free participants with heavy alcohol consumption registered in the Korean National Health Insurance Service database between 2005 and 2008 were enrolled. Habitual changes in alcohol consumption between 2009 and 2012 were classified as sustained heavy drinking, reduced drinking, and absolute abstinence. The primary outcome measure was new-onset AF during the follow-up. To minimize the effect of confounding variables on outcome events, inverse probability of treatment weighting (IPTW) analysis was performed. Overall, 19 425 participants were evaluated. The absolute abstinence group showed a 63% lower incidence of AF (IPTW hazard ratio: 0.379, 95% confidence interval: 0.169–0.853) than did the sustained heavy drinking group. Subgroup analysis identified that abstinence significantly reduced incident AF in participants with normal body mass index and without hypertension, diabetes, dyslipidaemia, heart failure, stroke, chronic kidney disease, or coronary artery disease (all P-value <0.05). There was no statistical difference in incident AF in participants with reduced drinking compared with sustained heavy alcohol group. Absolute abstinence could reduce the incidence of AF in heavy alcohol drinkers. Comprehensive clinical measures and public health policies are warranted to motivate alcohol abstinence in heavy drinkers. In this study of 19 425 participants, we investigated whether alcohol consumption reduction was associated with lower risk of incident atrial fibrillation (AF) in individuals with chronic heavy alcohol consumption. The absolute abstinence significantly reduced incident AF, but reducing alcohol consumption was not associated with a lower incident AF. The benefit of absolute abstinence for incidence of AF was significantly identified in participants with normal body mass index and without hypertension, diabetes, dyslipidaemia, heart failure, stroke, chronic kidney disease, or coronary artery disease.

30 May 2018 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
DKDong-Hyeok Kim
Dong-Hyeok Kim
JCJong-Il Choi
Jong-Il Choi
KLKwang-No Lee
Kwang-No Lee
JAJinhee Ahn
Jinhee Ahn
SRSeung-Young Roh
Seung-Young Roh
YKYoung-Hoon Kim
Young-Hoon Kim
There is a controversy as to whether catheter ablation should be the first-line therapy for tachycardia-bradycardia syndrome (TBS) in patients with atrial fibrillation (AF). We aimed to investigate long-term clinical outcomes of catheter ablation in patients with TBS and AF. Among 145 consecutive patients who underwent catheter ablation of AF with TBS, 121 patients were studied. Among 121 patients, 11 (9.1%) received implantation of a permanent pacemaker during a mean 21 months after ablation. Length of pause on termination of AF was significantly greater in patients who received pacemaker implantation after ablation than those who underwent ablation only (7.9 ± 3.5 vs. 5.1 ± 2.1 s, p < 0.001). Using a multivariate model, a long pause of 6.3 s or longer after termination of AF was associated with the requirement to implant a permanent pacemaker after ablation (HR 1.332, 95% CI 1.115-1.591, p = 0.002). This study suggests that, in patients with AF predisposing to TBS, long pause on termination of AF predicts the need to implant a permanent pacemaker after catheter ablation.

SESang-Yong Eom
Sang-Yong Eom
AKAryun Kim
Aryun Kim
JLJu-Hee Lee
Ju-Hee Lee
SKSang Min Kim
Sang Min Kim
SLSang-Yeub Lee
Sang-Yeub Lee
DLDae-In LEE
Dae-In LEE
Exposure to fine particulate matter increases the risk of cardiovascular morbidity and mortality. Few studies have tested the beneficial effect of indoor air filtration intervention in patients with cardiovascular disease. The aim of this study is to investigate the effect of air filtration on mitigating cardiovascular health in patients with coronary artery disease. This randomized, double-blind, crossover study is conducted with 38 coronary artery disease patients. The intervention consists of the following three periods: two-week active and sham air filtration interventions, with a two-week washout period. The indoor PM2.5 concentration is continuously monitored during the entire study period. We measure the blood pressure, heart rate variability, baroreflex sensitivity, autonomic function test results, and endothelial function. The two-week active air filtration intervention for two weeks reduces the average indoor concentration of PM2.5 by 33.9%. The indoor PM2.5 concentration is significantly correlated to cross-correlation baroreflex sensitivity. Active air filtration is significantly associated with a decrease in the indicator of oxidative stress represented as 8-hydroxy-2′-deoxyguanosine. This study shows that a short-term air filtration intervention improved baroreflex sensitivity and might reduce oxidative stress in coronary artery disease patients. These findings suggest that the use of an air purifier could mitigate the recurrence of cardiovascular disease events in patients with coronary artery disease.

21 November 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KLKwang-No Lee
Kwang-No Lee
JCJong-Il Choi
Jong-Il Choi
YKYun Gi Kim
Yun Gi Kim
KBKi Yung Boo
Ki Yung Boo
DKDo Young Kim
Do Young Kim
YKYoung-Hoon Kim
Young-Hoon Kim
The Cockcroft-Gault (CG) formula is recommended to guide clinicians in the choice of the appropriate dosage for direct oral anticoagulants (DOACs). However, the performance of the CG formula varies depending on the patient’s age, weight, and degree of renal function. We aimed to compare the validity of the CG formula with that of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) formulae for dosing DOACs. A total of 6268 consecutive patients on anticoagulants for atrial fibrillation (AF) were retrospectively investigated. Among underweight and elderly patients, the CG formula underestimated renal function compared with the non-CG formulae. However, the concordant rate of drug indications between the CG and the non-CG formulae was approximately 94%. On-label uses under the three formulae were associated with a lower risk of major bleeding (but not thromboembolism) compared to warfarin. Although we found differences in estimating renal function and the proportions of drug indications between the CG and non-CG formulae, the risks of thromboembolism and major bleeding were similar to those with warfarin regardless of which formula was used.

1 January 2018 in Korean Circulation Journal
Verified
Journal Article
Open access
SRSeung-Young Roh
Seung-Young Roh
JSJaemin Shim
Jaemin Shim
KLKwang-No Lee
Kwang-No Lee
JAJinhee Ahn
Jinhee Ahn
DKDong-Hyeok Kim
Dong-Hyeok Kim
YKYoung-Hoon Kim
Young-Hoon Kim
Roh SY, et al. Korean Circ J. 2016 Sep;48:e59. https://doi.org/10.4070/kcj.2017.0327